NCT05814432: Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
- State
- Under way
- Phase
- Phase 3
- People
- 279 planned
- Started
- 16 Jan 2025
- Primary completion
- 1 Jul 2032
- Arms
- Single high dose arm
- Results
- None posted
- 14 Apr 2023: Trial registered
- 16 Jan 2025: Trial started